Exosome Research Market Boosts Innovation Across Reagents Kits And High Throughput Research Workflows
According to Deepa Pandey, who specializes in biotechnology and life sciences market intelligence, with 5+ years of experience in market research and industry analysis, the exosome research market is on a strong growth path, projected to rise from USD 263.48 million in 2026 to USD 1,120.51 million by 2035 at a 17.45% CAGR. Her analysis highlights dominant demand from cancer research, isolation workflows, and reagents & kits, with academic institutes leading end-user adoption. She also notes North America’s market leadership alongside rapid expansion in Asia Pacific. The competitive landscape is shaped by key players such as Thermo Fisher Scientific, Danaher, Merck KGaA, Bio-Techne, and QIAGEN, driving innovation across exosome research tools and platforms.
Last Updated : 09 June 2026
Category: Biotechnology
Insight Code: 5997
Format: PDF / PPT / Excel